Advisory Services Network’s CorMedix CRMD Stock Holding History

Advisory Services Network’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83.2K	Sell	10,600 -975	-8%	-$7.7K	﹤0.01%	2069
2026 Q1	$78.6K	Buy	+11,575	New	+$85.6K	﹤0.01%	2355
2025 Q4	–	Sell	-1,881	Closed	-$21.9K	–	2326
2025 Q3	$21.9K	Buy	+1,881	New	+$22.7K	﹤0.01%	2913
2025 Q1	–	Sell	-51,600	Closed	-$418K	–	1640
2024 Q4	$418K	Buy	+51,600	New	+$515K	0.01%	1131
2022 Q1	–	Sell	-15,000	Closed	-$68K	–	1467
2021 Q4	$68K	Sell	15,000 -2,000	-12%	-$9.93K	﹤0.01%	1376
2021 Q3	$79K	Buy	+17,000	New	+$99K	﹤0.01%	1352

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Advisory Services Network's CRMD Position: Q2 2026 in Review

Advisory Services Network reduced its CorMedix (CRMD) stake by 8.4% in Q2 2026, selling an estimated $7.7K and leaving 10,600 shares worth $83.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

Advisory Services Network first reported a position in CRMD in Q3 2021 and has held it in 6 quarters since. The position peaked at $418K in Q4 2024. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Advisory Services Network held 10,600 shares of CorMedix worth $83.2K as of Q2 2026.
Advisory Services Network sold 975 CorMedix shares in Q2 2026, an estimated $7.7K.
CorMedix made up ﹤0.01% of Advisory Services Network's portfolio in Q2 2026, its #2069 holding.
Advisory Services Network first reported a position in CorMedix in Q3 2021 and has held it in 6 quarters since.
Advisory Services Network's CorMedix position peaked at $418K in Q4 2024.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.